The purpose of this study is to demonstrate the safety and effectiveness of the THERMOCOOL SMARTTOUCH® SF catheters in the treatment of drug refractory symptomatic persistent atrial fibrillation (PsAF) during standard electrophysiology mapping and RF ablation procedures.
Principal Investigator: J. Brian DeVille, MD
Locations: Baylor Scott & White The Heart Hospital – Plano
Sponsor: Biosense Webster
IRB Number: 016-181
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: N/A
Penni Dolton, RN469.814.4735Penni.Dolton@BSWHealth.org
Heath Shirkey, RN469.814.4185Heath.Shirkey@BSWHealth.org
Prospective Review of the Safety and Effectiveness of the THERMOCOOL SMARTTOUCH SF Catheter Evaluation for Treating Symptomatic Persistent AF (PRECEPT)
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Health Care System's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Health Care System.